Quest Diagnostics, Inc. (DGX)
241.89
-1.39
(-0.57%)
USD |
NYSE |
Oct 23, 16:00
241.89
0.00 (0.00%)
Pre-Market: 20:00
Quest Diagnostics Price to Book Value : 3.486 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.486 |
| October 22, 2026 | 3.506 |
| October 21, 2026 | 3.444 |
| October 20, 2026 | 3.418 |
| October 19, 2026 | 3.386 |
| October 16, 2026 | 3.387 |
| October 15, 2026 | 3.447 |
| October 14, 2026 | 3.364 |
| October 13, 2026 | 3.322 |
| October 12, 2026 | 3.353 |
| October 09, 2026 | 3.329 |
| October 08, 2026 | 3.327 |
| October 07, 2026 | 3.273 |
| October 06, 2026 | 3.292 |
| October 05, 2026 | 3.347 |
| October 02, 2026 | 3.363 |
| October 01, 2026 | 3.331 |
| September 30, 2026 | 3.359 |
| September 29, 2026 | 3.395 |
| September 28, 2026 | 3.478 |
| September 25, 2026 | 3.459 |
| September 24, 2026 | 3.463 |
| September 23, 2026 | 3.410 |
| September 22, 2026 | 3.436 |
| September 21, 2026 | 3.584 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.607 |
| September 17, 2026 | 3.622 |
| September 16, 2026 | 3.616 |
| September 15, 2026 | 3.616 |
| September 14, 2026 | 3.482 |
| September 11, 2026 | 3.440 |
| September 10, 2026 | 3.383 |
| September 09, 2026 | 3.446 |
| September 08, 2026 | 3.447 |
| September 04, 2026 | 3.471 |
| September 03, 2026 | 3.504 |
| September 02, 2026 | 3.524 |
| September 01, 2026 | 3.457 |
| August 31, 2026 | 3.517 |
| August 28, 2026 | 3.553 |
| August 27, 2026 | 3.58 |
| August 26, 2026 | 3.586 |
| August 25, 2026 | 3.578 |
| August 24, 2026 | 3.569 |
| August 21, 2026 | 3.577 |
| August 20, 2026 | 3.532 |
| August 19, 2026 | 3.538 |
| August 18, 2026 | 3.458 |
| August 17, 2026 | 3.447 |
| August 14, 2026 | 3.430 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Labcorp Holdings, Inc. | 3.092 |
| DaVita, Inc. | -- |
| OPKO Health, Inc. | 1.027 |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.701 |
Price to Book Value Related Metrics
| PE Ratio | 24.08 |
| PS Ratio | 2.288 |
| PEG Ratio | 1.348 |
| Price to Free Cash Flow | 19.70 |
| Price | 241.89 |
| Earnings Yield | 4.15% |
| Market Cap | 26.61B |
| PEGY Ratio | 1.25 |
| Operating PE Ratio | 15.50 |
| Normalized PE Ratio | 21.96 |